Seguir
Ying Wan
Ying Wan
Analytical Research & Development, Merck Research Laboratories, Merck & Co., Inc.
Dirección de correo verificada de merck.com
Título
Citado por
Citado por
Año
Decreased abundance of type III secretion system-inducing signals in Arabidopsis mkp1 enhances resistance against Pseudomonas syringae
JC Anderson, Y Wan, YM Kim, L Pasa-Tolic, TO Metz, SC Peck
Proceedings of the National Academy of Sciences 111 (18), 6846-6851, 2014
1072014
Separation of zinc-dependent and zinc-independent events during early LPS-stimulated TLR4 signaling in macrophage cells
Y Wan, MJ Petris, SC Peck
FEBS letters 588 (17), 2928-2935, 2014
392014
Development of stabilizing formulations of a trivalent inactivated poliovirus vaccine in a dried state for delivery in the Nanopatch™ microprojection array
Y Wan, JM Hickey, C Bird, K Witham, P Fahey, A Forster, SB Joshi, ...
Journal of Pharmaceutical Sciences 107 (6), 1540-1551, 2018
202018
Formulation Development and Improved Stability of a Combination Measles and Rubella Live-Viral Vaccine Dried for Use in the NanopatchTM Microneedle …
Y Wan, V Gupta, C Bird, SR Pullagurla, P Fahey, A Forster, DB Volkin, ...
Human vaccines & immunotherapeutics 17 (8), 2501-2516, 2021
132021
Genetic dissection of Arabidopsis MAP kinase phosphatase 1-dependent PAMP-induced transcriptional responses
L Jiang, Y Wan, JC Anderson, J Hou, SM Islam, J Cheng, SC Peck
Journal of experimental botany 68 (18), 5207-5220, 2017
102017
Analytical and preformulation characterization studies of human papillomavirus virus-like particles to enable quadrivalent multi-dose vaccine formulation development
K Jerajani, Y Wan, JM Hickey, OS Kumru, N Sharma, SR Pullagurla, ...
Journal of Pharmaceutical Sciences 111 (11), 2983-2997, 2022
62022
Multi-dose formulation development for a quadrivalent human papillomavirus virus-like particle-based vaccine: part II-Real-time and accelerated stability studies
N Sharma, K Jerajani, Y Wan, OS Kumru, SR Pullagurla, O Ogun, ...
Journal of Pharmaceutical Sciences 112 (2), 458-470, 2023
32023
Multi-dose formulation development for a quadrivalent human papillomavirus virus-like particle-based vaccine: part I-screening of preservative combinations
K Jerajani, Y Wan, OS Kumru, SR Pullagurla, P Kumar, N Sharma, ...
Journal of Pharmaceutical Sciences 112 (2), 446-457, 2023
32023
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–8